ArticleIn vivo (Athens, Greece)

Survival Outcomes in Patients With Locally Advanced NSCLC Converted to Resectable Disease by Neoadjuvant Therapy.

Ece Duygu Gulsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.